This is the fourth NIH grant SINTX has earned since receiving a phase 1 award in September 2021, according to an Oct. 11 news release. About 40 percent of spine implants are PEEK-based devices because of their proven clinical efficacy.
SINTX plans to spend the next 24 months collaborating with the Philadelphia-based University of Pennsylvania School of Veterinary Medicine on 3D-printed versions of the implant.
Upon the execution of phase 2 of the project, SINTX will have the majority of the data needed to earn FDA 510(k) clearance, according to the report.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
